Vobiwin Trio 1mg/500mg/0.2mg Tablet
Marketer
Ranmarc Labs
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Vobiwin Trio 1mg/500mg/0.2mg Tablet
TriadDiabetica (1mg/500mg/0.2mg) tablets are classified as antidiabetic agents, a combination medication for adult type 2 diabetes management. This formulation aids in regulating blood glucose. TriadDiabetica should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be limited due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.
Primary Ingredients of Vobiwin Trio 1mg/500mg/0.2mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Vobiwin Trio 1mg/500mg/0.2mg Tablet
Managing Type 2 Diabetes
Major Benefits of Vobiwin Trio 1mg/500mg/0.2mg Tablet:
Consume Vobiwin Trio 1mg/500mg/0.2mg Tablet exactly as prescribed by your physician. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Vobiwin Trio 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Vobiwin Trio 1mg/500mg/0.2mg Tablet:
Consume Vobiwin Trio 1mg/500mg/0.2mg Tablet precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Vobiwin Trio 1mg/500mg/0.2mg Tablet works:
Each Vobiwin Trio tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Vobiwin Trio 1mg/500mg/0.2mg Tablet use is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Vobiwin Trio 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Vobiwin Trio 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Vobiwin Trio 1mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. Furthermore, its use is discouraged in those with severe kidney impairment.
LiverCAUTION
Patients with liver disease should use Vobiwin Trio 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver impairment, initiating treatment with a low dose is typical; however, Vobiwin Trio 1mg/500mg/0.2mg tablets are not recommended for patients with severe liver disease.
What if you forget to take Vobiwin Trio 1mg/500mg/0.2mg Tablet :
Should you forget a dose of Vobiwin Trio 1mg/500mg/0.2mg Tablet, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose at one time.
Facts to Know About Vobiwin Trio 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently